These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 7911025

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
    Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, Shimosato Y.
    Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
    [Abstract] [Full Text] [Related]

  • 3. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H, Yonemura Y, Hirono Y, Ninomiya I, Sahara H, Tsugawa K, Matsumoto H, Sugiyama K, Fujimura T, Nishimura G.
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
    Kim JP, Oh ST, Hwang TS, Chi JG.
    J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
    [Abstract] [Full Text] [Related]

  • 6. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P, Christodoulou P, Kapralos P, Exarchakos M, Bisbiroula A, Hadjiyannakis M, Georgountzos C, Thomas-Tsagli E.
    Pathol Res Pract; 1997 Jun; 193(11-12):767-75. PubMed ID: 9521509
    [Abstract] [Full Text] [Related]

  • 7. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E, Kamina S, Athanassiadou S, Agnantis NJ.
    Anticancer Res; 1996 Jun; 16(5B):3141-7. PubMed ID: 8920782
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA, Mannel RS, Haraway SD, Walker J, Min KW.
    Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
    [Abstract] [Full Text] [Related]

  • 11. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
    Dabbs DJ.
    Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P.
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Correlation of p53 expression and proliferative activity in gastric cancer.
    Yonemura Y, Fushida S, Tsugawa K, Ninomiya I, Fonseca L, Yamaguchi A, Miyazaki I, Urano T, Shiku H.
    Anal Cell Pathol; 1993 Sep; 5(5):277-88. PubMed ID: 8105878
    [Abstract] [Full Text] [Related]

  • 17. Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma.
    Kanaji S, Saito H, Tsujitani S, Matsumoto S, Tatebe S, Kondo A, Ozaki M, Ito H, Ikeguchi M.
    Oncology; 2006 Sep; 70(2):126-33. PubMed ID: 16645325
    [Abstract] [Full Text] [Related]

  • 18. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
    Korkolopoulou P, Oates J, Crocker J, Edwards C.
    J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
    [Abstract] [Full Text] [Related]

  • 19. [Immunohistochemical study of growth factors and oncogenes in gastric carcinomas].
    Yamagiwa H, Onishi N, Onishi T, Onishi T, Onishi H, Satomoto K, Watanabe K, Nishii M.
    Rinsho Byori; 1993 Jul; 41(7):795-9. PubMed ID: 8103127
    [Abstract] [Full Text] [Related]

  • 20. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A, Margaria E, Chiusa L.
    J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.